LTGO · Latigo Biotherapeutics, Inc. · Held by Funds
$15.26
+0.24 (+1.60%)
At close · Oct 26
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 3, 2026
The latest filing states the doubt was alleviated.
“Accordingly, the prior substantial doubt about the Company's ability to continue as a going concern has been alleviated.”View the 10-Q filed Sep 3, 2026
Market Cap
$954.38M
Shares
66.30M
Volume · Oct 26
165.33K
Avg daily vol (56 sessions)
349.92K
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding LTGO
3 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| Select Biotechnology Portfolio | FBIOX | 480,316 | $10,576,558 | 0.17% | Long | 2026-08-31 | |
| Select Health Care Portfolio | — | 212,500 | $4,679,250 | 0.07% | Long | 2026-08-31 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | FCTDX | 78,500 | $1,728,570 | 0.00% | Long | 2026-08-31 |
Showing 1–3 of 3 positions